X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8366) 8366
Book Chapter (216) 216
Newspaper Article (54) 54
Dissertation (24) 24
Book / eBook (4) 4
Magazine Article (3) 3
Publication (3) 3
Trade Publication Article (2) 2
Newsletter (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6998) 6998
life sciences & biomedicine (6058) 6058
humans (4884) 4884
cognitive ability (4789) 4789
neurosciences & neurology (4138) 4138
neurosciences (3773) 3773
male (3715) 3715
female (3397) 3397
alzheimer's disease (3011) 3011
aged (2539) 2539
dementia (2263) 2263
magnetic resonance imaging (1995) 1995
neurology (1934) 1934
middle aged (1929) 1929
clinical neurology (1867) 1867
brain (1863) 1863
memory (1680) 1680
neurodegenerative diseases (1548) 1548
neuroimaging (1515) 1515
alzheimers disease (1355) 1355
psychiatry (1318) 1318
cognition (1316) 1316
biomarkers (1289) 1289
mild cognitive impairment (1286) 1286
aged, 80 and over (1209) 1209
neuropsychological tests (1167) 1167
animals (1153) 1153
neuroscience (1151) 1151
studies (1124) 1124
aging (1072) 1072
adult (1047) 1047
medicine (1031) 1031
research (1030) 1030
risk factors (1029) 1029
alzheimer’s disease (995) 995
mental disorders (968) 968
proteins (968) 968
science & technology - other topics (927) 927
cerebrospinal fluid (924) 924
multidisciplinary sciences (923) 923
research article (898) 898
brain research (896) 896
patients (865) 865
geriatrics & gerontology (849) 849
medical imaging (838) 838
analysis (829) 829
dementia disorders (826) 826
science (826) 826
hippocampus (809) 809
neurodegeneration (776) 776
cortex (756) 756
brain - pathology (747) 747
nervous system (747) 747
inflammation (740) 740
age (720) 720
diagnosis (706) 706
nuclear magnetic resonance--nmr (706) 706
medical research (704) 704
cognitive impairment (689) 689
cognition & reasoning (683) 683
cognitive dysfunction - diagnosis (665) 665
pathology (656) 656
disease progression (651) 651
alzheimer disease - diagnosis (631) 631
health aspects (624) 624
rodents (624) 624
alzheimer disease - pathology (602) 602
older people (586) 586
care and treatment (583) 583
psychology (582) 582
atrophy (559) 559
brain mapping (547) 547
neural networks (541) 541
medicine, experimental (537) 537
review (512) 512
cognitive dysfunction - pathology (498) 498
case-control studies (493) 493
mice (488) 488
development and progression (486) 486
metabolism (486) 486
neurons (465) 465
functional magnetic resonance imaging (464) 464
biomarkers - cerebrospinal fluid (461) 461
tau protein (457) 457
geriatrics (445) 445
cognitive dysfunction - physiopathology (442) 442
cell biology (434) 434
social sciences (433) 433
alzheimer disease - cerebrospinal fluid (428) 428
cognitive neuroscience (428) 428
cognition disorders (426) 426
brain - metabolism (425) 425
disease (423) 423
cognitive dysfunction - cerebrospinal fluid (419) 419
brain - diagnostic imaging (418) 418
physiological aspects (415) 415
cognitive dysfunction - diagnostic imaging (411) 411
biomedicine (404) 404
young adult (399) 399
radiology, nuclear medicine & medical imaging (396) 396
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8639) 8639
German (15) 15
Spanish (11) 11
Japanese (9) 9
Norwegian (9) 9
Portuguese (9) 9
Chinese (5) 5
French (5) 5
Russian (3) 3
Turkish (3) 3
Dutch (2) 2
Arabic (1) 1
Danish (1) 1
Finnish (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of neurovirology, ISSN 1538-2443, 10/2015, Volume 22, Issue 2, pp. 191 - 200
.... We evaluated the relationship between cell-free mtDNA in cerebrospinal fluid (CSF) and neurocognitive performance and inflammation during HIV infection... 
Neurology | Neurosciences | Biomedicine | Immunology | Infectious Diseases | Pleocytosis | Mitochondrial DNA | Inflammation | Droplet digital PCR | HAND | Virology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | DNA, Mitochondrial - cerebrospinal fluid | Chemokine CCL2 - immunology | Lipopolysaccharide Receptors - cerebrospinal fluid | Humans | Memory | Middle Aged | Tumor Necrosis Factor-alpha - genetics | Male | Antigens, CD - genetics | Learning | Neurofilament Proteins - cerebrospinal fluid | Chemokine CCL2 - cerebrospinal fluid | HIV Infections - immunology | Neurofilament Proteins - genetics | Cognitive Dysfunction - immunology | Tumor Necrosis Factor-alpha - immunology | Interleukin-6 - cerebrospinal fluid | Antigens, Differentiation, Myelomonocytic - cerebrospinal fluid | HIV Infections - cerebrospinal fluid | Gene Expression | Interleukin-6 - genetics | Tumor Necrosis Factor-alpha - cerebrospinal fluid | Lipopolysaccharide Receptors - immunology | Cognitive Dysfunction - cerebrospinal fluid | Cognitive Dysfunction - pathology | Receptors, Cell Surface - immunology | Neuropsychological Tests | Antigens, CD - cerebrospinal fluid | HIV Infections - complications | Interleukin-6 - immunology | Receptors, Cell Surface - genetics | Antigens, CD - immunology | HIV-1 - physiology | HIV Infections - pathology | Chemokine CXCL10 - immunology | Adult | Female | Neopterin - immunology | Cognitive Dysfunction - complications | Neurofilament Proteins - immunology | Executive Function | Antigens, Differentiation, Myelomonocytic - immunology | Severity of Illness Index | Chemokine CXCL10 - cerebrospinal fluid | Neopterin - cerebrospinal fluid | Cross-Sectional Studies | Chemokine CCL2 - genetics | Antigens, Differentiation, Myelomonocytic - genetics | Chemokine CXCL10 - genetics | Lipopolysaccharide Receptors - genetics | Index Medicus
Journal Article
Brain (London, England : 1878), ISSN 1460-2156, 11/2015, Volume 138, Issue 11, pp. 3373 - 3385
Journal Article
JAMA neurology, ISSN 2168-6149, 12/2018, Volume 76, Issue 3, pp. 318 - 325
...: To investigate cerebrospinal fluid (CSF) levels of neurofilament light (NFL) protein, a marker of neuroaxonal degeneration, in control participants and patients with dementia, motor neuron disease, and parkinsonian disorders... 
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Frontotemporal Dementia - cerebrospinal fluid | Parkinsonian Disorders - cerebrospinal fluid | Humans | Middle Aged | Parkinsonian Disorders - diagnosis | Dementia - diagnosis | Male | Intermediate Filaments - metabolism | Case-Control Studies | Alzheimer Disease - diagnosis | Neurofilament Proteins - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Cognition - physiology | Dementia - cerebrospinal fluid | Female | Cognitive Dysfunction - diagnosis | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Motor Neuron Disease - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Frontotemporal Dementia - diagnosis | Parkinson Disease - diagnosis | Aged | Biomarkers - cerebrospinal fluid | Motor Neuron Disease - diagnosis | Brain | Parkinson's disease | Cognitive ability | Disorders | Impairment | Cognition | Cerebrospinal fluid | Proteins | Motor neuron diseases | Autopsy | Neurodegeneration | Dementia disorders | Degeneration | Paralysis | Light levels | Alzheimer's disease | Movement disorders | Autopsies | Neurodegenerative diseases | Motor neurone disease | Amyotrophic lateral sclerosis | Disease control | Lewy bodies | Diseases | Neurological diseases | Cognition & reasoning | Tau protein | Progressive supranuclear palsy | Correlation analysis | β-Amyloid | Frontotemporal dementia | Dementia | Index Medicus | Abridged Index Medicus | Neurosciences | Neurovetenskaper
Journal Article
Sleep (New York, N.Y.), ISSN 1550-9109, 01/2017, Volume 40, Issue 5
...) cerebrospinal fluid (CSF) biomarkers in OSA patients. Therefore, we first studied cognitive performances, polysomnographic sleep, and CSF beta-amyloid 42, tau proteins, and lactate levels in patients affected by subjective cognitive impairment (SCI... 
β-Amyloid | Subjective cognitive decline | Lactate | Continuous positive airway pressure | Obstructive sleep apnea | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Continuous Positive Airway Pressure | Sleep Apnea, Obstructive - therapy | Sleep Apnea, Obstructive - physiopathology | Alzheimer Disease - complications | Intelligence | Humans | Memory | Sleep Apnea, Obstructive - cerebrospinal fluid | Male | Sleep Apnea, Obstructive - complications | Cognition | Memory Disorders - complications | Cognitive Dysfunction - prevention & control | Alzheimer Disease - prevention & control | Early Medical Intervention | Cognitive Dysfunction - therapy | Amyloid beta-Peptides - cerebrospinal fluid | Female | Cognitive Dysfunction - complications | Memory Disorders - cerebrospinal fluid | Peptide Fragments - cerebrospinal fluid | Alzheimer Disease - therapy | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Polysomnography | Neuropsychological Tests | Memory Disorders - prevention & control | Sleep | Lactic Acid - cerebrospinal fluid | Memory Disorders - therapy | Aged | Biomarkers - cerebrospinal fluid | Early Diagnosis | Biomarkers | Sleep apnea | Alzheimers disease | Insomnia | Index Medicus
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 01/2015, Volume 11, Issue 1, pp. 40 - 50.e2
.... SPMs were analyzed in cerebrospinal fluid (CSF). Results SPMs and SPM receptors were detected in the human brain... 
Neurology | Human | Immunohistochemistry | Lipoxin A4 | Mild cognitive impairment | Tau | ALX/FPR2 | 15-Lipoxygenase-2 | ChemR23 | FPRL1 | Resolvin D1 | ELISA | Specialized pro-resolving mediators | 15‐Lipoxygenase‐2 | Specialized pro‐resolving mediators | Lipoxin A | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Inflammation - pathology | Humans | Middle Aged | Male | Cognitive Dysfunction - enzymology | Case-Control Studies | Lipoxins - cerebrospinal fluid | Alzheimer Disease - pathology | Inflammation Mediators - cerebrospinal fluid | Inflammation - metabolism | Lipoxygenase - cerebrospinal fluid | Inflammation Mediators - metabolism | Receptors, Formyl Peptide - analysis | Amyloid beta-Peptides - cerebrospinal fluid | Female | Hippocampus - enzymology | Inflammation - cerebrospinal fluid | Hippocampus - pathology | tau Proteins - cerebrospinal fluid | Alzheimer Disease - enzymology | Cognitive Dysfunction - cerebrospinal fluid | Cognitive Dysfunction - pathology | Alzheimer Disease - cerebrospinal fluid | Receptors, Lipoxin - analysis | Hippocampus - metabolism | Docosahexaenoic Acids - cerebrospinal fluid | Alzheimer Disease - metabolism | Aged | Biomarkers - cerebrospinal fluid | Inflammation - enzymology | Inflammation | Analgesics | Alzheimer's disease | Neurophysiology | Index Medicus | 15-lipoxygenase-2 | LXA4R | lipoxin A4 | resolvin D1 | specialized pro-resolving mediators | tau | mild cognitive impairment | immunohistochemistry | human
Journal Article
Anesthesia and analgesia, ISSN 0003-2999, 11/2019, Volume 129, Issue 5, pp. e150 - e154
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 01/2015, Volume 11, Issue 1, pp. 58 - 69
Journal Article